abstract |
Compound (I) of the present invention: [Chemical 1] Or a method for reducing or inhibiting FLT3 kinase activity in a cell or subject using a solvate, hydrate, tautomer or pharmaceutically acceptable salt thereof, and subjecting said compound to the subject In order to prevent or treat cell proliferative diseases and / or FLT3-related diseases. The present invention is further directed to methods of treating conditions such as cancer and other cell proliferative disorders. |